Showing 1 - 20 results of 31 for search 'Quentin M Anstee', query time: 0.10s
Refine Results
-
1
Handling Overlapping Asymmetric Data Sets—A Twice Penalized P-Spline Approach by Matthew McTeer, Robin Henderson, Quentin M. Anstee, Paolo Missier
Published 2024-03-01
Article -
2
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational stu... by Helen Jarvis, Dawn Craig, Robert Barker, Gemma Spiers, Daniel Stow, Quentin M Anstee, Barbara Hanratty
Published 2020-04-01
Article -
3
-
4
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis. by Jenny Lee, Yasaman Vali, Jérôme Boursier, Kevin Duffin, Joanne Verheij, M Julia Brosnan, Koos Zwinderman, Quentin M Anstee, Patrick M Bossuyt, Mohammad Hadi Zafarmand
Published 2020-01-01
Article -
5
Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitu... by Quentin M. Anstee, Tina L. Berentzen, Louise M. Nitze, Maximilian Jara, Anders B. Jensen, Mette S. Kjær, Kamal K. Mangla, Jens M. Tarp, Kamlesh Khunti
Published 2024-01-01
Article -
6
Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study by Yasaman Vali, Roel Eijk, Timothy Hicks, William S. Jones, Jana Suklan, Adriaan G. Holleboom, Vlad Ratziu, Miranda W. Langendam, Quentin M. Anstee, Patrick M. M. Bossuyt
Published 2022-05-01
Article -
7
FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis... by Vincent Wai-Sun Wong, Quentin M. Anstee, Louise M. Nitze, Anja Geerts, Jacob George, Victor Nolasco, Mette S. Kjær, Steen Ladelund, Philip N. Newsome, Vlad Ratziu
Published 2023-12-01
Article -
8
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis by Jenny Lee, Yasaman Vali, Jérôme Boursier, Kevin Duffin, Joanne Verheij, M. Julia Brosnan, Koos Zwinderman, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand, Pavel Strnad
Published 2020-01-01
Article -
9
FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis by Yasaman Vali, Jenny Lee, Jérôme Boursier, René Spijker, Joanne Verheij, M. Julia Brosnan, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand, on behalf of the LITMUS Systematic Review Team
Published 2021-05-01
Article -
10
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis by Lorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, Yemi Oluboyede, Luke Vale, Laura Ternent, Maria-Magdalena Balp, Lynda Doward, Clifford A. Brass, Fiona Beyer, Arun Sanyal, Quentin M. Anstee
Published 2020-06-01
Article -
11
Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease by Anne-Marieke Van Dijk, Yasaman Vali, Anne Linde Mak, Jenny Lee, Maarten E. Tushuizen, Mohammad Hadi Zafarmand, Quentin M. Anstee, M. Julia Brosnan, Max Nieuwdorp, Patrick M. Bossuyt, Adriaan G. Holleboom
Published 2021-06-01
Article -
12
Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH by Quentin M. Anstee, Jeremy Magnanensi, Yacine Hajji, Alexandra Caron, Zouher Majd, Christian Rosenquist, Dean W. Hum, Bart Staels, Margery A. Connelly, Rohit Loomba, Stephen A. Harrison, Vlad Ratziu, Arun J. Sanyal
Published 2024-04-01
Article -
13
The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326 by Brian E. Ford, Shruti S. Chachra, Katrina Rodgers, Tabassum Moonira, Ziad H. Al-Oanzi, Quentin M. Anstee, Helen L. Reeves, Jörn M. Schattenberg, Rebecca J. Fairclough, David M. Smith, Dina Tiniakos, Loranne Agius
Published 2023-06-01
Article -
14
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease by Aidan J. McGlinchey, Olivier Govaere, Dawei Geng, Vlad Ratziu, Michael Allison, Jerome Bousier, Salvatore Petta, Claudia de Oliviera, Elisabetta Bugianesi, Jörn M. Schattenberg, Ann K. Daly, Tuulia Hyötyläinen, Quentin M. Anstee, Matej Orešič
Published 2022-05-01
Article -
15
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes by Zobair M Younossi, Vincent Wai‐Sun Wong, Quentin M. Anstee, Manuel Romero‐Gomez, Michael H. Trauner, Stephen A. Harrison, Eric J. Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P. Myers, Zachary Goodman, Maria Stepanova
Published 2020-11-01
Article -
16
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease by Partho Sen, Olivier Govaere, Tim Sinioja, Aidan McGlinchey, Dawei Geng, Vlad Ratziu, Elisabetta Bugianesi, Jörn M. Schattenberg, Antonio Vidal-Puig, Michael Allison, Simon Cockell, Ann K. Daly, Tuulia Hyötyläinen, Quentin M. Anstee, Matej Orešič
Published 2022-09-01
Article -
17
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. by Stuart McPherson, Nina Wilkinson, Dina Tiniakos, Jennifer Wilkinson, Alastair D Burt, Elaine McColl, Deborah D Stocken, Nick Steen, Jane Barnes, Nicola Goudie, Stephen Stewart, Yvonne Bury, Derek Mann, Quentin M Anstee, Christopher P Day
Published 2017-01-01
Article -
18
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease by Marie Boyle, Dina Tiniakos, Jorn M. Schattenberg, Vlad Ratziu, Elisabetta Bugianessi, Salvatore Petta, Claudia P. Oliveira, Olivier Govaere, Ramy Younes, Stuart McPherson, Pierre Bedossa, Mette J Nielsen, Morten Karsdal, Diana Leeming, Stuart Kendrick, Quentin M. Anstee
Published 2019-09-01
Article -
19
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease by Anne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, Yasaman Vali, Guruprasad P. Aithal, Jörn M. Schattenberg, Quentin M. Anstee, M. Julia Brosnan, Mohammad Hadi Zafarmand, Dewkoemar Ramsoekh, Stephen A. Harrison, Max Nieuwdorp, Patrick M. Bossuyt, Adriaan G. Holleboom
Published 2021-12-01
Article -
20
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study by Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee
Published 2020-10-01
Article